General Information of the Compound
Compound ID
CP0911850
Compound Name
1-(2-(piperidin-1-yl)ethyl)-4-o-tolyl-1H-pyrazolo[3,4-d]pyrimidine
    Show/Hide
Structure
Formula
C19H23N5
Molecular Weight
321.428
Canonical SMILES
Cc1ccccc1-c1ncnc2c1cnn2CCN1CCCCC1
    Show/Hide
InChI
InChI=1S/C19H23N5/c1-15-7-3-4-8-16(15)18-17-13-22-24(19(17)21-14-20-18)12-11-23-9-5-2-6-10-23/h3-4,7-8,13-14H,2,5-6,9-12H2,1H3
    Show/Hide
InChIKey
JCGLBNCCKIEYFL-UHFFFAOYSA-N
Physicochemical Property
logP
3.28762
Rotatable Bonds
4
Heavy Atom Count
24
Polar Areas
46.84
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
5
Complexity
24

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 74766964
ChEMBL ID
CHEMBL4288125
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01509, Sigma non-opioid intracellular receptor 1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
Ki = 74 nM
   TI
   LI
   LO
   TS